A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(37 sites)

United States

Vima Site #033, Birmingham, Alabama

Vima Site #039, Scottsdale, Arizona

Vima Site #004, Scottsdale, Arizona

Vima Site #028, Sun City, Arizona

Vima Site #042, Irvine, California

Vima Site #030, Los Angeles, California

Vima Site #019, Denver, Colorado

Vima Site #009, Gainesville, Florida

Vima Site #008, Miami, Florida

Vima Site #031, Orlando, Florida

Vima Site #005, Atlanta, Georgia

Vima Site #027, Chicago, Illinois

Vima Site #041, Overland Park, Kansas

Vima Site #043, Baltimore, Maryland

Vima Site #007, Olney, Maryland

Vima Site #032, Boston, Massachusetts

Vima Site #037, East Lansing, Michigan

Vima Site #002, Farmington Hills, Michigan

Vima Site #038, St Louis, Missouri

Vima Site #014, Albuquerque, New Mexico

Vima Site #024, New York, New York

Vima Site #036, Rochester, New York

Vima Site #040, Fayetteville, North Carolina

Vima Site #035, Cincinnati, Ohio

Vima Site #029, Portland, Oregon

Vima Site #020, Philadelphia, Pennsylvania

Vima Site #021, Charleston, South Carolina

Vima Site #016, Memphis, Tennessee

Vima Site #006, Nashville, Tennessee

Vima Site #025, Dallas, Texas

Vima Site #026, Georgetown, Texas

Vima Site #012, Houston, Texas

Vima Site #013, Houston, Texas

Vima Site #011, Richmond, Virginia

Vima Site #023, Kirkland, Washington

Vima Site #015, Spokane, Washington